搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
2 天
Ozempic vs. Wegovy: What’s the Difference?
Ozempic and Wegovy are two popular injectable medications for weight loss and diabetes. But what’s the difference?
1 天
Dr. Roach: Ozempic dosage can be increased if/when a plateau is reached
Wegovy and Ozempic are the exact same drug: semaglutide. They are dosed slightly differently and marketed for different ...
煎蛋 on MSN
4 天
Ozempic有望改变阿尔茨海默病治疗格局
两项重磅试验2025年揭晓 ...
dailymemphian
1 天
‘It’s bonkers’ — how Ozempic, Wegovy change lives of those who struggle to lose weight
The medications are so common now, two-thirds of the clinic’s calls for insurance pre-authorizations are for the big three: ...
腾讯网
5 天
“诺礼”减肥神药主流化背后 适用性、医保等新挑战悄然而至
去年这个时候,人们还在争论诺和诺德(NVO.US)的Wegovy和礼来(LLY.US)的Zepbound是减肥的捷径还是医学上的突破。但是,随着大量数据表明这些药物的健康益处不仅仅是减少肥胖——包括减轻心脏病、糖尿病、慢性肾病和睡眠呼吸暂停——大多数 ...
FiercePharma
1 天
2025 forecast: After Novo, Lilly expansion sprees, 'positive signals' emerge around future ...
Following rapid (and pricey) expansion efforts from Novo and Lilly, plus recent shortage updates at the FDA, “positive ...
9 小时
on MSN
Why comments from well-meaning relatives on your weight can be so distressing
The holidays can be a difficult time for those with a history of eating disorders, and having someone comment on their body – ...
4 小时
GLP-1 questions emerge for 2025
The weight-loss market began feeling some growing pains as the year ended, creating more wariness for the upcoming year. For 2025, competition and supply constraints are areas to watch.
2 天
on MSN
Gen Z is skipping the gym and turning to weightloss drugs — leading the Ozempic craze
The majority of Americans now believe these medications are more effective than traditional weight loss methods like diet and exercise.
1 天
on MSN
2024 was the year of weight loss for Floridians. Wondering why?
For Floridians, 2024 was a year of weight loss and emerging revelations about anti-obesity medications.
13 天
on MSN
Pennsylvania Medicaid spent nearly $300 million on Wegovy and other anti-obesity drugs
Pennsylvania's Medicaid spending per enrollee on Wegovy, Zepbound, and other anti-obesity drugs was third-highest in the ...
11 天
Zepbound helps shed more weight than Wegovy, Eli Lilly study says
A new study put Eli Lilly's Zepbound and Novo Nordisk's Wegovy to the test. Here's which one will help you lose more weight.
当前正在显示可能无法访问的结果。
隐藏无法访问的结果
反馈